1. Colorectal Cancer Screening: How to Stop a Moving Target
Leo G.M. van Rossum 
Clinical Gastroenterology and Hepatology 
Volume 10, Issue 6, Pages (June 2012)
DOI: /j.cgh
Copyright © 2012 AGA Institute Terms and Conditions

2. Figure 1
Optimal cumulative sensitivity for colorectal cancer and advanced adenomas. Sensitivity for a single iFOBT is set to 60% for colorectal cancer and 30% for advanced adenomas.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2012 AGA Institute Terms and Conditions